Skip to main content
logo
Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
5.31
+0.21 (4.12%)
Aug 10, 2026, 4:00 PM EDT - Market closed

Jupiter Neurosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.040.02--0.23-
Revenue Growth
------
Gross Profit
0.030.02--0.23-
Operating Income
-13.9-8.91-3.09-3.87-3.43-3.87
Net Income
-9.18-8.64-2.44-4.78-4.96-4.78
Earnings Per Share
-0.25-18.75-6.00-13.50-0.19-0.20
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0000.030.060.33
Total Debt
4.835.320.222.251.91
Net Cash (Debt)
-4.83-5.32-0.22-2.22-1.83-0.67
Net Cash Growth
------
Net Cash Per Share
-0.13-11.52-0.57-6.31-0.07-0.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.41-5.41-3.91-0.48-1.25-1.74
Free Cash Flow
-3.41-5.41-3.91-0.48-1.25-1.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
78.76%80.59%--100.00%-
Operating Margin
-34354.40%-40873.20%---1471.38%-
Pretax Margin
-33969.35%-39662.77%---2125.15%-
Profit Margin
-33969.30%-39662.80%---2125.15%-
FCF Margin
-8442.38%-24838.20%---535.19%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
76.01120904.00----